GEMAYEL GEORGES bought SUPN

March 6, 2026 · Form 4 insider transaction

GEMAYEL GEORGES bought 7,905 shares of Supernus Pharmaceuticals, Inc. at $25.30 per share, a transaction worth $200.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
7,905
Price
$25.30
Total value
$200.0K
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 6, 2026
Filing dateMarch 9, 2026
Shares owned after36,064
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR